Genetics

This blog post explores a critical cross-sectional study that evaluates the efficacy of Polygenic Risk Scores (PRS) for Multiple Sclerosis (MS) across diverse ancestral backgrounds. Utilizing genomic and health data from the "All of Us" Research Program, researchers found that while current PRS models—largely based on European genetic data—effectively stratify risk for individuals of European and Latino/admixed American ancestries, they fail to provide significant risk categorization for individuals of African ancestry. These findings underscore a significant disparity in precision medicine, highlighting that the genetic architecture of MS differs across populations and that "one-size-fits-all" genetic tools may inadvertently exclude certain groups. Ultimately, the study calls for a fundamental shift toward more inclusive, ancestry-specific genetic research to ensure that advancements in MS risk prediction and clinical trial stratification are accurate and equitable for all patients.